Mount Kisco Medical Group at Northern Westchester Hospital

Mount Kisco, New York 10549-3417

1 studies enrolling now · 8 studies all time

What they study most

ALK Gene Rearrangement, ALK Gene Translocation, ALK Positive, Breast Adenocarcinoma, Breast Cancer, Glioblastoma Multiforme, HER2/Neu Positive, Lung Non-Squamous Non-Small Cell Carcinoma, Malignant Neoplasm, Progesterone Receptor Positive, Recurrent Breast Carcinoma, Stage IA Breast Cancer AJCC v7

Studies at this site

• Molecular Genetics Studies of Cancer Patients and Their Relatives — Recruiting now
• Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) — Running, not enrolling
• Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) — Running, not enrolling
• Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer — Running, not enrolling
• Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) — Running, not enrolling
• Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer — Completed
• A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer — Completed
• Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme — Completed